চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

novartis s.r.o., praha array - 15556 oktreotid-acetÁt - prášek a rozpouštědlo pro injekční suspenzi - 20mg - oktreotid

চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

novartis s.r.o., praha array - 15556 oktreotid-acetÁt - prášek a rozpouštědlo pro injekční suspenzi - 30mg - oktreotid

চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

ucb s.r.o., praha array - 16445 levocetirizin-dihydrochlorid - potahovaná tableta - 5mg - levocetirizin

চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

ucb s.r.o., praha array - 12076 cetirizin-dihydrochlorid - perorální kapky, roztok - 10mg/ml - cetirizin

চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

ucb s.r.o., praha array - 12076 cetirizin-dihydrochlorid - potahovaná tableta - 10mg - cetirizin

ইউরোপীয় ইউনিয়ন - চেক - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - imunosupresiva - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

ইউরোপীয় ইউনিয়ন - চেক - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - povrchové antigeny viru chřipky (hemaglutinin a neuraminidáza) kmene a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vakcíny - aktivní imunizace proti podtypu h5n1 viru chřipky a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

ইউরোপীয় ইউনিয়ন - চেক - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunologická vyšetření pro kanyziary - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

potraviny pro zvlÁŠtnÍ lÉkaŘskÉ ÚČely (pzlÚ) (ČeskÁ atc skupina)